Behavioral Intervention to Reduce Chemical Exposure in Pregnancy
Effectiveness of a multicOmpoNent Behavioural intervenTion to Reduce endocrINe disrUptor Exposure During pErinatal Period (CONTINUE)
Recruiting
N/A
Interventional Study
Pregnancy
Children
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 810 (estimated)
- Sponsor
- Fundació Institut Germans Trias i Pujol · Other
Who this trial is looking for
This trial is looking for pregnant women who want to learn about reducing chemical exposure during pregnancy and after childbirth. Participants will engage in a program aimed at lowering harmful chemicals while receiving support and information.
Are You a Good Fit for This Trial?
You may be able to join if
- I am pregnant and have a viable pregnancy confirmed by ultrasound.
- I plan to breastfeed.
- I can read Dutch, French, Spanish, Catalan, or Polish.
- I am at least 18 years old.
- I have a smartphone or can borrow one for the study.
- My BMI is between 18.5 and 40.
- I am between 6 and 11 weeks pregnant.
You may not be able to join if
- I cannot sign informed consent.
- I have a substance abuse issue.
- I have been taking certain medications that affect hormones.
- I am pregnant with twins or more.
- I have type 1 or type 2 diabetes.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The general objective of HYPIEND is to understand the effects of chemical substances called "endocrine disruptors" (EDCs) during the perinatal and pre-pubertal stages. EDCs co-exposure may affect the function of hormones and determine endocrine consequences in vulnerable populations.
The primary objective of this clinical study is to demonstrate that a multicomponent intervention implemented in h…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Pregnant women with a viable pregnancy confirmed by ultrasound until 13 weeks and 0 days of gestation (recruitment between 6-11 weeks). Their partners will be invited to participate but this is not mandatory for inclusion.
* BMI at Visit 1 between 18.5-40 kg/m²
* Intention to …
Contacts